Funding for digital health companies enjoyed explosive growth in 2021, but has retreated significantly as health systems, payors, and investors take a closer look at value demonstration, management teams, and customer validation. Join Joe Kvedar and Lisa Suennen, CEO of Venture Valkyrie and advisor to venture companies across the healthcare spectrum, discuss what investors are looking for now. What’s realistic and expected when considering revenue, savings, and valuations?   What level of validation is really required and how do VCs make the right match between company and fund? According to Suennen, health tech investing like entering into a marriage, you need to find a compatible partner with the same goals. Hear her perspective on today’s market and where it’s going.This episode is made possible by Ziegler Healthcare Investment Banking.

Ver todos los episodios